Guangdong, China

Wenfei Liang

This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Guangzhou Dazhou Biomedicine Ltd.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Wenfei Liang

Introduction

Wenfei Liang is a notable inventor based in Guangdong, China. He has made significant strides in the field of biomedical engineering, particularly in drug delivery systems. His work focuses on developing innovative solutions to improve patient care and treatment efficacy.

Latest Patents

Wenfei Liang holds a patent for a transdermal drug delivery system for ketamine. This patent includes transdermal delivery devices, such as monolithic transdermal patches, designed to administer ketamine effectively. The invention aims to treat various diseases and disorders, including depression, anxiety, and pain, providing a non-invasive method for medication delivery.

Career Highlights

Liang is currently associated with Guangzhou Dazhou Biomedicine Ltd., where he continues to advance his research and development efforts. His contributions to the field have been recognized for their potential impact on therapeutic practices.

Collaborations

Wenfei Liang collaborates with esteemed colleagues, including Huadong Tang and Hock Seng Tan. Their combined expertise enhances the innovative capabilities of their projects and fosters a collaborative environment for research.

Conclusion

Wenfei Liang's work exemplifies the importance of innovation in the biomedical field. His patent for a transdermal drug delivery system represents a significant advancement in treatment options for patients. The ongoing research and collaboration with his peers further highlight his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…